Positron emission tomography (PET) is generally considered to be a quantitative imaging modality, allowing assessment of regional differences in radiotracer accumulation and the derivation of quantitative physiological information. Due to the increasing complexity of PET technology, the quantitative accuracy of PET images has to be continually reassessed if PET is to maintain its quantitative reputation. In this commentary, we discuss the results from a recent inter-scanner study in which the quantitative outcome measures from human studies were compared for three different radiotracers. The approach is a useful complement to standard phantom tests such as those prescribed by NEMA, but the resulting data are more difficult to interpret.
S
ince its inception, positron emission tomography (PET) has benefited from a reputation for quantitative accuracy. This quantitative capability helped drive its technological development and was recognized in the early literature [1] , "The combination of the quantitative tomographic capabilities of PETT III, the importance of physiological information, and the unique properties of positron radionuclides provide a great potential for developing diagnostic and experimental capabilities." As PET technology has become increasingly complex, the quantitative accuracy of the resulting images has been continually reassessed. This systematic appraisal of accuracy is crucial if we are to maintain confidence in our quantitative interpretations. Important technological advances included the transition from 2D to 3D acquisition, the extension of the axial length of the detectors (now 25 cm or more), the decrease in the size of scintillator detector elements, the production of combined (sequential) PET-CT scanners, the acquisition and use of time-of-flight measurements, and recently the introduction of combined (sequential or simultaneous) PET-MR scanners. Despite providing various clinical benefits, each of these advances also brings a real possibility of reducing quantification accuracy. For example, 3D acquisition increases the proportion of coincidences in which one or both annihilation photons underwent a scattering event, and makes accurate scatter correction more challenging and more important; the use of time-of-flight measurements can lead to artifacts in the image if the timing kernel used in the reconstruction is incorrect; the estimation of the attenuation correction from MR data (or misaligned or incomplete CT data) is non-trivial and can lead to errors in quantification.
In the current issue, van Velden et al. [2] compare the results from imaging subjects on a relatively modern brain PET scanner (the high resolution research tomograph; HRRT [3] ) with those from imaging the same subjects on an older, whole-body PET scanner (the HR+ in 3D mode [4, 5] ). The authors make use of one of the important techniques by which quantification accuracy can be tested: assessment against a gold standard. In this case, the authors take the data acquired with the HR+ to implicitly represent the gold standard with the aim of verifying results from the HRRT. The study hence sits at one end of the "validation spectrum," which has simulations at the other, and phantom studies and manipulations of human datasets in-between. The study is reported approximately 10 years after the HRRT was introduced, allowing ample time for key software fixes to be implemented, includes a large number of subjects (n=16) and three different radiotracers. A limitation of the approach is the uncertain accuracy of the gold standard, which hinders the interpretation of any differences. To borrow language from Heller's classic novel Catch-22, do the differences represent a "black eye" or a "feather in the cap" for the newer system? To unravel this question, we examine the choice of gold standard, and draw on supporting literature in which the quantification accuracies of the HRRT and HR+ have been assessed. Subsequently, we ask what the imaging community should learn from these findings. But first let us back-pedal, and consider the design of the two scanners in question.
The ECAT EXACT HR+ (Siemens/CTI) (Knoxville, Tennessee, USA) [4, 5] was developed in the mid-1990s. This whole-body scanner has retractable tungsten septa allowing acquisition in either 2D or 3D mode. Photon attenuation is measured in 2D using rotating Ge-68 rod sources. Phantom studies suggest the 3D attenuation correction derived from these transmission measurements can be erroneous near regions of air or bone, producing localized errors in activity concentrations of about 10 % [4] [5] [6] . The scatter correction provided by the single scatter simulation [7, 8] appears robust for this scanner, particularly when the neuro-shield is used to reduce scattering from outside the field of view. The image reconstruction algorithm, filtered back projection (FBP), is linear and considered accurate.
The HRRT (Siemens/CTI) (Knoxville, TN, USA) [3] is a 3D PET brain scanner developed around the turn of the century. Compared to the HR+, the scanner has a different method of photon attenuation measurement (singles-mode using a rotating Cs-137 source), a longer axial extent (25 vs. 15.5 cm) and narrower diameter (47 vs. 83 cm), and different detectors (8 planar phoswich LSO/LYSO detector arrays vs. 288 BGO block detectors for the HR+). With smaller detector elements, projection bins for the HRRT are smaller than those for the HR+ leading to fewer counts per bin. To make use of its superior spatial resolution, the HRRT uses smaller image voxels than the HR+, and hence collects fewer counts per voxel. The scatter correction used on the HRRT was recently improved to become more accurate [9] . The algorithm for attenuation correction for the HRRT was also recently improved, with the so-called "μ-maps" shown to be in reasonable agreement with those derived from CT [10] . The choice of algorithm settings for scatter and attenuation corrections for the HRRT is however nontrivial and strongly affects quantification accuracy and uniformity [11] . The iterative reconstruction method chosen by van Velden et al. for the HRRT is known to generate biased results for low-count data [12, 13] .
In van Velden et al.'s comparison [2] , systematic differences between the HRRT and HR+ were in the range −13 to +15 % depending on the tracer and method of analysis. Considering the results from various other studies along our validation spectrum [3] [4] [5] [6] [9] [10] [11] [12] [13] [14] [15] [16] , it is reasonable to attribute some, but not all, of the inter-scanner differences to inaccuracies in the processing of HRRT data. The comparison hence highlights and quantifies how differences in scanner performance, as previously found in phantom studies, translates to differences in the outcome measures from human data. The study did not determine the origin of the differences, and this must surely be the next task for the dedicated investigator. Indeed, various manipulations of the data presented by van Velden et al. together with phantom studies should enable the main sources of inter-scanner differences to be pinpointed and then overcome, be it simply the choice of reconstruction algorithm (iterative for the HRRT compared with FBP for the HR+) or factors such as scatter and attenuation corrections. Systematic investigations of this type do however require significant time-investments.
Errors of 10-15 % would be acceptable for many studies but troublesome for others. If a scanner (or the chosen methods of data processing) provides images with regionally specific biases, it is problematic for studies that combine data from that scanner with data from other scanners in large multicenter studies, aim to accurately quantify regional differences in uptake, or aim to provide absolute quantification of physiological processes within these error bounds. Studies comparing two populations (e.g., diseased vs. controls) or that have a longitudinal design using a single scanner are impacted to a lesser extent.
When interpreting quantitative PET data (and semiquantitative standardized uptake values (SUV)) clinicians should be aware of the potential impact of the scanner and reconstruction algorithm on the outcome values; this is of particular importance when imaging is used for disease monitoring in an individual, or when literature-values are used as a benchmark [17, 18] . This naturally extends to the planning of multicenter trials, where it is advisable to limit the number of different scanners in use, and to pay close attention to the possibility of inter-scanner differences in quantification [19, 20] . Long-term longitudinal research spanning the lifetime of more than one PET scanner can also fall victim to quantification differences between scanners, and in these studies it is advisable to perform careful quantification testing prior to decommissioning an old scanner to allow comparison with its replacement. Even after resolution matching, the possibility of differences in quantification remains.
What else does this study teach us? It highlights the fact that data obtained from different scanners should not only be compared using standard phantom tests, such as those prescribed by NEMA, but that it is also important to compare quantitative outcome measures from human studies using a variety of radiotracer distributions. Differences in such measures might be predictable when phantom data highlight systematic differences (e.g., in regional uniformity) [11, 14] , but unexpected in other cases. The sometimes erroneous performance of the HRRT's scatter correction that occurs for tracers that have high uptake in the scalp is an example of the latter [16] . Indeed, it is non-trivial to accurately reproduce the complex matter and radioactivity distributions present in human studies using phantoms. This aspect of inter-scanner comparison is well-demonstrated by van Velden's study; unfortunately, a conclusive explanation of the exact source of differences in outcome measures was beyond the scope of the reported study, leaving the reader's appetite only partially satiated. This could yet be achieved using targeted validation studies which dissect specific aspects of algorithm or hardware performance. Such a multifaceted approach for the validation of other new scanners is ardently encouraged, is currently abundant in the form of MR-derived attenuation correction, and is necessary if PET is to maintain its quantitative reputation.
